Skip Navigation


Cardiovascular Research Advance Access originally published online on December 3, 2008
Cardiovascular Research 2009 81(4):660-668; doi:10.1093/cvr/cvn338
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
81/4/660    most recent
cvn338v2
cvn338v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Guo, R.-W.
Right arrow Articles by Huang, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guo, R.-W.
Right arrow Articles by Huang, L.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

An essential role for stromal interaction molecule 1 in neointima formation following arterial injury

Rui-Wei Guo1,{dagger}, Hong Wang1,{dagger}, Pan Gao1, Mao-Quan Li2, Chun-Yu Zeng3, Yang Yu1, Jian-Fei Chen1, Ming-Bao Song1, Yan-Kun Shi1 and Lan Huang1,*

1 Department of Cardiology, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China
2 Department of Public Health, Chengdu Medical College, Chengdu 610000, China
3 Department of Cardiology, Daping Hospital, Third Military Medical University, Chongqing 400037, China

* Corresponding author. Tel: +86 23 68755601; fax: +86 23 68755601. E-mail address: huanglan260{at}126.com

Aims: There is evidence to suggest that stromal interaction molecule 1 (STIM1) functions as a Ca2+ sensor on the endoplasmic reticulum, leading to transduction of signals to the plasma membrane and opening of store-operated Ca2+ channels (SOC). SOC have been detected in vascular smooth muscle cells (VSMCs) and are thought to have an essential role in the regulation of contraction and cell proliferation. We hypothesized that knockdown of STIM1 inhibits VSMC proliferation and suppresses neointimal hyperplasia.

Methods and results: We examined the effect of the knockdown of STIM1 using a rat balloon injury model and cultured rat aortic VSMCs. Interestingly, knockdown of rat STIM1 by adenovirus delivery of small interfering RNA (siRNA) significantly suppressed neointimal hyperplasia in a rat carotid artery balloon injury model at 14 days after injury. The re-expression of human STIM1 to smooth muscle reversed the effect of STIM1 knockdown on neointimal formation. Rat aortic VSMCs were used for the in vitro assays. Knockdown of endogenous STIM1 significantly inhibited proliferation and migration of VSMCs. Moreover, STIM1 knockdown induced cell-cycle arrest in G0/G1 and resulted in a marked decrease in SOC. Replenishment with recombinant human STIM1 reversed the effect of siRNA knockdown. These results suggest STIM1 has a critical role in neointimal formation in a rat model of vascular injury.

Conclusion: STIM1 may represent a novel therapeutic target in the prevention of restenosis after vascular interventions.

KEYWORDS STIM1; VSMC proliferation; Neointimal; Vascular injury; Restenosis


Time for primary review: 27 days

{dagger} R-W.G. and H.W. contributed equally to this work.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Article

STIM1: a new therapeutic target in occlusive vascular disease?
Alex Agrotis and Christine Koulis
Cardiovasc Res 2009 81: 627-628. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Cardiovasc ResHome page
A. Agrotis and C. Koulis
STIM1: a new therapeutic target in occlusive vascular disease?
Cardiovasc Res, March 1, 2009; 81(4): 627 - 628.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.